Patents for C12P 19 - Preparation of compounds containing saccharide radicals (43,092)
03/2001
03/22/2001CA2379541A1 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications
03/21/2001EP1085096A2 Preparation of high trehalose content product
03/21/2001EP1084267A1 Vitamin c production in microorganisms and plants
03/21/2001EP1083980A2 Modulation of molecular interaction sites on rna and other biomolecules
03/21/2001EP1083920A1 Novel antibacterial compounds
03/21/2001EP1083919A1 Novel antiviral compounds
03/21/2001EP1053352A4 Mismatch detection techniques
03/21/2001CN1288484A Method for processing sucrose into glucose
03/21/2001CN1288384A Lipooligosaccharide-based vaccine for prevention of i(moraxella) i(branhamella) i (catarrhalis) infections in mammals
03/21/2001CN1288058A Novel nucleotide series with coded pgi gene
03/20/2001US6204431 Transgenic non-human mammals expressing heterologous glycosyltransferase DNA sequences produce oligosaccharides and glycoproteins in their milk
03/20/2001US6204377 Kojibiose phosphorylase glucosyl-saccharides produced by transglycosylation
03/20/2001US6204041 Deregulation of glutamine PRPP amidotransferase activity
03/20/2001US6204029 Mixture of activated glycoside derivitive, mutant glycosyltransferase, acceptor substrate, and nucleotide phosphate or analog
03/20/2001US6204006 Microbial strains producing sphingolipid bases
03/20/2001US6204000 Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1
03/20/2001CA2033657C Glucose isomerases having altered substrate specificity
03/15/2001WO2001018226A1 Method for producing exopolysaccharides
03/15/2001WO2000029603A8 Low cost manufacture of oligosaccharides
03/15/2001DE19925073A1 Nucleinsäuremoleküle mit spezifischer Erkennung von nativem PrP·S··c·, Herstellung und Verwendung Nucleic acid molecules with specific detection of native PrP c · S · · ·, production and use
03/15/2001CA2318507A1 Novel nucleotide sequences coding for the pgi gene
03/14/2001EP1083234A1 Process for producing l-ribose
03/14/2001EP1083222A2 Endo-xyloglucan transferase
03/14/2001EP1082456A1 Antisense modulation of cd40 expression
03/14/2001EP1082440A1 LIPOPOLYSACCHARIDE $g(a)-2,3 SIALYLTRANSFERASE OF $i(CAMPYLOBACTER JEJUNI) AND ITS USES
03/13/2001US6201005 Method for inhibiting lymphokine production
03/13/2001US6200813 Altering substrate specificity of polyketide synthase by isolating genomic dna fragments which encode acyltransferase domain, transforming cell having one fragment with other fragment for homologous recombination; antibiotics
03/13/2001US6200784 Process for the selective preparation of derivatives of monosaccharides and polyols which are partially acylated
03/13/2001US6200782 Fusion proteins linked to nucleotide sequences; for the preferential adjustment of nucleotide sequences
03/08/2001WO2001016377A2 Diagnostics and therapeutics for osteoporosis
03/08/2001WO2001016366A2 Template-dependent nucleic acid polymerization using oligonucleotide triphosphates building blocks
03/08/2001WO2001016349A1 Method for production of maltose and/or enzymatically modified starch
03/08/2001WO2001016348A1 Maltogenic amylase-modified starch derivatives
03/08/2001WO2001016312A2 Nucleic acid based modulators of gene expression
03/08/2001WO2001016303A2 Nucleic acids which code for the enzyme activities of the spinosyn biosynthesis
03/08/2001WO2001016149A2 2-azapurine compounds and their use
03/08/2001WO2000073501A3 Nucleic acid molecules with specific identification of native prpsc, their production and the use thereof
03/08/2001WO2000068395A3 Sulfohydrolases, corresponding amino acid and nucleotide sequences, sulfohydrolase preparations, processes, and products thereof
03/08/2001WO1999064047A8 Novel antiviral compounds
03/08/2001DE19957268A1 Nucleinsäuren, die für Enzymaktivitäten der Spinosyn-Biosynthese kodieren Nucleic acids which encode enzyme activities of spinosyn biosynthesis
03/08/2001CA2403243A1 Nucleic acid based modulators of gene expression
03/08/2001CA2382657A1 Template-dependent nucleic acid polymerization using oligonucleotide triphosphates building blocks
03/08/2001CA2308049A1 Diagnostic and therapeutic methods in autoimmune disease
03/07/2001EP1081230A2 Process for producing N-acetyl-neuraminic acid
03/07/2001EP1080633A1 Method for transforming plant, the resultant plant and gene thereof
03/07/2001EP1080229A1 Chemically assembled nano-scale devices
03/07/2001EP1080225A1 Compositions and methods for the pulmonary delivery of nucleic acids
03/07/2001EP1080186A2 Method for altering the activity of proteins of the pka signaling pathway
03/07/2001EP0915935B1 4,7-dichlororhodamine dyes
03/07/2001CN1286692A Substances KF-1040 and process for producing same
03/07/2001CN1286308A Method for producing N-acetylneuraminic acid
03/06/2001US6197591 Nucleotide sequence which control the transcription of a preferential antibiotic
03/06/2001US6197584 Antisense modulation of CD40 expression
03/06/2001US6197566 α-galactosidase enzyme
03/06/2001US6197563 Accumulation of nucleotide sequences; for diagnosis of infections and screening for nucleotide sequence polymorphisms
03/06/2001US6197552 Efficient method by contacting 2'-deoxyribose-1-phosphoric acid or salt and 2,6-diaminopurine with microorganism or lysate which produces 2,6-diaminopurine-2'-deoxyriboside, then contacting with adenosine deaminase in aqueous medium
03/01/2001WO2001014575A1 Process for producing glycosides
03/01/2001WO2001014568A1 Taq dna polymerases having an amino acid substitution at e681 and homologs thereof exhibiting improved salt tolerance
03/01/2001WO2001014566A2 Enzymatic synthesis of deoxyribonucleosides
03/01/2001WO2001014535A2 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-β1,3-N-ACETYLGALACTOSAMINE-α-R/(GlcNAc to GalNAc) β1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2GnT3
03/01/2001WO2001014522A1 Novel yeast variants and process for producing glycoprotein containing mammalian type sugar chain
03/01/2001WO2001014394A2 Derivatized reduced malto-oligosaccharides
03/01/2001WO2000049413A3 Rapid assay for arthropod-borne disease vectors and pathogens
03/01/2001CA2382462A1 Enzymatic synthesis of deoxyribonucleosides
03/01/2001CA2382184A1 Novel yeast mutants and process for producing glycoprotein containing mammalian type sugar chain
03/01/2001CA2381856A1 Process for producing glycosides
03/01/2001CA2381206A1 Taq dna polymerases having an amino acid substitution at e681 and homologs thereof exhibiting improved salt tolerance
02/2001
02/28/2001EP1078101A2 Solution hybridization of nucleic acids with antisense probes having modified backbones
02/28/2001EP1078100A1 Quantitative method for detecting nucleotide concentration
02/28/2001CN1285877A Use of oxidation promoting chemicals in the oxidation of oxidizable galactose type of alcohol configuration containing polymer
02/28/2001CN1285871A i (dull 1) coding for a starch synthase and uses thereof
02/28/2001CN1285848A Oxidation in solid state of oxidizable galactose type of alcohol configuration containing polymer
02/28/2001CN1285411A Acetyl-tyrothricin and process for preparing 5-fluorouridine using same as enzyme precursor
02/27/2001US6194546 Influenza virus haemagglutinin which has a heterologous epitope at antigenic site a; vaccines against foot-and-mouth disease, poliovirus, human rhinovirus, hepatitis b virus, plasmodium and bacteria
02/27/2001US6194192 Method of purifying and removing viruses
02/27/2001US6194179 Method for preparing polynucleotide sequences and uses thereof
02/27/2001US6194178 Method for the production of sialylated oligosaccharides
02/27/2001CA2213775C Cancer metastasis inhibitor containing a streptococcus agalactiae ia type or ib type surface polysaccharide as a main ingredient
02/27/2001CA2110582C Modified sialyl lewis a compounds
02/22/2001WO2001012834A1 Process for the preparation and simultaneous separation of enzyme-catalysed products
02/22/2001WO2001012826A2 Nucleic acid molecules derived from plants which code for enzymes which are involved in the synthesis of starch
02/22/2001WO2001012822A1 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
02/22/2001WO2001012821A1 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
02/22/2001WO2001012817A1 Evolution and use of enzymes for combinathorial and medicinal chemistry
02/22/2001WO2001012782A2 Transgenically modified plant cells and plants having modified gbssi- and be-protein activity
02/22/2001WO2000061731A3 Modified starch metabolism enzymes and encoding genes for improvement and optimization of plant phenotypes
02/22/2001DE19937643A1 Transgene Zellen und Pflanzen mit veränderter Aktivität des GBSSI- und des BE-Proteins Transgenic cells and plants with altered activity of the GBSSI and BE protein
02/22/2001DE19937348A1 Nukleinsäuremoleküle aus Pflanzen codierend Enzyme, die an der Stärkesynthese beteiligt sind Nucleic acid molecules encoding enzymes from plants, which are involved in starch synthesis
02/22/2001CA2381427A1 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
02/22/2001CA2381163A1 Transgenically modified plant cells and plants having modified gbssi- and be-protein activity
02/22/2001CA2380948A1 Evolution and use of enzymes for combinathorial and medicinal chemistry
02/22/2001CA2378173A1 Nucleic acid molecules derived from plants which code for enzymes which are involved in the synthesis of starch
02/21/2001EP1077261A2 A process for the fermentative preparation of metabolic products and for the nucleotide sequences encoding sod
02/21/2001EP1076716A1 Functional sugar polymers from inexpensive sugar sources and apparatus for preparing same
02/21/2001EP0765401B1 Primer extension mass spectroscopy nucleic acid sequencing method
02/21/2001EP0646135B1 Food ingredient comprising a gel obtained from plant matter
02/21/2001CN1284564A Method for production of D-arabitol, D-xyloketose and xylitol
02/21/2001CN1284560A Fermentation prep. of metabolic products and nucleotide sequence of code sod gene
02/20/2001US6191271 Synthetic divalent sLex containing polylactosamines and methods for use
02/20/2001US6190888 Process for making riboflavin glucoside